Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the ...

Mise à jour : Il y a 4 ans
Référence : ISRCTN53821378

Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux

Extrait

Not provided at time of registration


Critère d'inclusion

  • Chronic hepatitis C

Liens